independent physician-scientist and founder of Nyx Dynamics LLC. My research spans four intersecting domains: HIV prevention implementation science, algorithmic epidemiology, computational neuroscience, and clinical decision support validation.
My methodological toolkit includes Monte Carlo simulation, Hierarchical Bayesian inference, causal inference frameworks, time series analysis (ARIMA/SARIMA/DFT), and natural language processing. Active manuscripts span Journal of Infectious Diseases, PLOS Computational Biology, BMC Public Health, and Viruses.
Core research contributions include: (1) population-scale validation of a LAI-PrEP bridge period clinical decision support tool at 21.2M patient scale with demonstrated 11:1 ROI; (2) a mathematical theorem formalizing finite HIV post-exposure prophylaxis windows under irreversible infection establishment; (3) a multiplicative barrier model demonstrating interaction-dominant algorithmic discrimination dynamics (87.6% three-way interaction effect); and (4) a noise decorrelation hypothesis for phase-specific neurometabolic outcomes in HIV neuroinflammation.
I co-authored Connecticut's Getting to Zero HIV elimination strategy and hold a provisional patent on quantum coherence protection systems. MIT MicroMasters in Statistics & Data Science (in progress).
🔗 nyxdynamics.org/research | ORCID: 0000-0002-9216-8569
independent physician-scientist and founder of Nyx Dynamics LLC. My research spans four intersecting domains: HIV prevention implementation science, algorithmic epidemiology, computational neuroscience, and clinical decision support validation.
My methodological toolkit includes Monte Carlo simulation, Hierarchical Bayesian inference, causal inference frameworks, time series analysis (ARIMA/SARIMA/DFT), and natural language processing. Active manuscripts span Journal of Infectious Diseases, PLOS Computational Biology, BMC Public Health, and Viruses.
Core research contributions include: (1) population-scale validation of a LAI-PrEP bridge period clinical decision support tool at 21.2M patient scale with demonstrated 11:1 ROI; (2) a mathematical theorem formalizing finite HIV post-exposure prophylaxis windows under irreversible infection establishment; (3) a multiplicative barrier model demonstrating interaction-dominant algorithmic discrimination dynamics (87.6% three-way interaction effect); and (4) a noise decorrelation hypothesis for phase-specific neurometabolic outcomes in HIV neuroinflammation.
I co-authored Connecticut's Getting to Zero HIV elimination strategy and hold a provisional patent on quantum coherence protection systems. MIT MicroMasters in Statistics & Data Science (in progress).
🔗 nyxdynamics.org/research | ORCID: 0000-0002-9216-8569